Secondary mania related to acquired immunodeficiency syndrome (AIDS). Case report

Introduction Neuropsychiatric manifestations in human immunodeficiency virus (HIV) infection are uncommon but salient once they emerge to the surface. These symptoms can be the result of direct or indirect effects of the virus on the central nervous system (CNS). In particular, HIV related mania ca...

Full description

Bibliographic Details
Main Authors: D. C. Gliția, R. Cozma, C. A. Crișan
Format: Article
Language:English
Published: Cambridge University Press 2023-03-01
Series:European Psychiatry
Online Access:https://www.cambridge.org/core/product/identifier/S0924933823014542/type/journal_article
_version_ 1797616765741563904
author D. C. Gliția
R. Cozma
C. A. Crișan
author_facet D. C. Gliția
R. Cozma
C. A. Crișan
author_sort D. C. Gliția
collection DOAJ
description Introduction Neuropsychiatric manifestations in human immunodeficiency virus (HIV) infection are uncommon but salient once they emerge to the surface. These symptoms can be the result of direct or indirect effects of the virus on the central nervous system (CNS). In particular, HIV related mania can complicate any stage of the infection but increases its frequency with the progression of HIV infection to the final stage. Objectives The objective of this case report is to rase awareness about secondary mania due to HIV infection and the importance of etiological treatment in mental disorders. Methods We herein report the case of a 27-year-old, male patient, who was admitted to our Psychiatric Clinic I Cluj-Napoca, with a 3-week history of typical manic symptoms such as: elated mood, alternating with episodes of irritability, talking too much, familiarity, multiple future plans, hypersexuality, social disinhibition and decreased need for sleep. Throughout the hospitalization, the course of the manic symptomatology did not improve, additionally the patient started to exhibit neurological symptoms accompanied by complex visual hallucinations. Prior to this episode he reported depressive symptoms, predominantly anhedonia, apathy, and social withdrawal but without meeting the clinical severity threshold. The patient had no family history of a mental disorder. A psychopharmacological treatment was initiated (atypical antipsychotic Quetiapine XR 300 mg/day initially, and then switched to Olanzapine 10 mg/day, mood stabilizer Valproic Acid 1,5 g/day), but he developed significant extrapyramidal side effects. Results Blood tests revealed: leukopenia, lymphopenia, thrombocytopenia, subsequently hepatic cytolysis, and high CRP. Psychometric evaluation revealed: Young Mania Rating Scale (YMRS) score 33/60 – moderate mania, Positive and Negative Syndrome Scale (PANSS)- total score 51 (16/49 Positive; 7/49 Negative; 28/112 General Psychopathology). MRI: T2 and FLAIR hyperintense extended areas in the bilateral periventricular white matter and in the internal capsule. The anamnesis, heteroanamnesis, paraclinical investigations led us to a diagnosis of secondary mania related to HIV infection. The patient was transferred to the Infectious Diseases Clinical Hospital for a targeted antiretroviral therapy (Raltegravir 800 mg/day, Emtricitabine/Tenofovir disoproxil 200mg/245 mg). Conclusions Recognizing and controlling HIV secondary mania should be of high importance given its association with heightened sexual behavior and substance abuse which can result in an elevated risk of transmitting the infection to other people. Disclosure of Interest None Declared
first_indexed 2024-03-11T07:46:00Z
format Article
id doaj.art-211c86be78b64e939bedf6f355381f93
institution Directory Open Access Journal
issn 0924-9338
1778-3585
language English
last_indexed 2024-03-11T07:46:00Z
publishDate 2023-03-01
publisher Cambridge University Press
record_format Article
series European Psychiatry
spelling doaj.art-211c86be78b64e939bedf6f355381f932023-11-17T05:07:31ZengCambridge University PressEuropean Psychiatry0924-93381778-35852023-03-0166S695S69510.1192/j.eurpsy.2023.1454Secondary mania related to acquired immunodeficiency syndrome (AIDS). Case reportD. C. Gliția0R. Cozma1C. A. Crișan2Psychiatry I, Infectious Diseases Clinical Hospital Cluj-NapocaPsychiatry I, Emergency County Hospital Cluj-NapocaDepartment of Neurosciences, Discipline of Psychiatry and Pediatric Psychiatry, Iuliu Hațieganu University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania Introduction Neuropsychiatric manifestations in human immunodeficiency virus (HIV) infection are uncommon but salient once they emerge to the surface. These symptoms can be the result of direct or indirect effects of the virus on the central nervous system (CNS). In particular, HIV related mania can complicate any stage of the infection but increases its frequency with the progression of HIV infection to the final stage. Objectives The objective of this case report is to rase awareness about secondary mania due to HIV infection and the importance of etiological treatment in mental disorders. Methods We herein report the case of a 27-year-old, male patient, who was admitted to our Psychiatric Clinic I Cluj-Napoca, with a 3-week history of typical manic symptoms such as: elated mood, alternating with episodes of irritability, talking too much, familiarity, multiple future plans, hypersexuality, social disinhibition and decreased need for sleep. Throughout the hospitalization, the course of the manic symptomatology did not improve, additionally the patient started to exhibit neurological symptoms accompanied by complex visual hallucinations. Prior to this episode he reported depressive symptoms, predominantly anhedonia, apathy, and social withdrawal but without meeting the clinical severity threshold. The patient had no family history of a mental disorder. A psychopharmacological treatment was initiated (atypical antipsychotic Quetiapine XR 300 mg/day initially, and then switched to Olanzapine 10 mg/day, mood stabilizer Valproic Acid 1,5 g/day), but he developed significant extrapyramidal side effects. Results Blood tests revealed: leukopenia, lymphopenia, thrombocytopenia, subsequently hepatic cytolysis, and high CRP. Psychometric evaluation revealed: Young Mania Rating Scale (YMRS) score 33/60 – moderate mania, Positive and Negative Syndrome Scale (PANSS)- total score 51 (16/49 Positive; 7/49 Negative; 28/112 General Psychopathology). MRI: T2 and FLAIR hyperintense extended areas in the bilateral periventricular white matter and in the internal capsule. The anamnesis, heteroanamnesis, paraclinical investigations led us to a diagnosis of secondary mania related to HIV infection. The patient was transferred to the Infectious Diseases Clinical Hospital for a targeted antiretroviral therapy (Raltegravir 800 mg/day, Emtricitabine/Tenofovir disoproxil 200mg/245 mg). Conclusions Recognizing and controlling HIV secondary mania should be of high importance given its association with heightened sexual behavior and substance abuse which can result in an elevated risk of transmitting the infection to other people. Disclosure of Interest None Declaredhttps://www.cambridge.org/core/product/identifier/S0924933823014542/type/journal_article
spellingShingle D. C. Gliția
R. Cozma
C. A. Crișan
Secondary mania related to acquired immunodeficiency syndrome (AIDS). Case report
European Psychiatry
title Secondary mania related to acquired immunodeficiency syndrome (AIDS). Case report
title_full Secondary mania related to acquired immunodeficiency syndrome (AIDS). Case report
title_fullStr Secondary mania related to acquired immunodeficiency syndrome (AIDS). Case report
title_full_unstemmed Secondary mania related to acquired immunodeficiency syndrome (AIDS). Case report
title_short Secondary mania related to acquired immunodeficiency syndrome (AIDS). Case report
title_sort secondary mania related to acquired immunodeficiency syndrome aids case report
url https://www.cambridge.org/core/product/identifier/S0924933823014542/type/journal_article
work_keys_str_mv AT dcglitia secondarymaniarelatedtoacquiredimmunodeficiencysyndromeaidscasereport
AT rcozma secondarymaniarelatedtoacquiredimmunodeficiencysyndromeaidscasereport
AT cacrisan secondarymaniarelatedtoacquiredimmunodeficiencysyndromeaidscasereport